Back to Search
Start Over
The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
- Source :
-
Trials . 1/19/2017, Vol. 18, p1-9. 9p. 1 Diagram. - Publication Year :
- 2017
-
Abstract
- <bold>Background: </bold>Medication non-adherence is a complex health care problem. Due to non-adherence, substantial numbers of cardiovascular patients benefit from their medication to only a limited extent. In order to improve adherence, a variety of pharmacist-led interventions have been developed. However, even the most effective interventions achieved only a modest positive effect. To be effective, interventions should be targeted at underlying barriers to adherence, developed in a systematic manner and tailored to specific features of a target group and setting. The current paper describes the design of the Cardiovascular medication non-Adherence Tailored Intervention (CATI) study aimed to evaluate the (cost-)effectiveness of a patient-tailored intervention programme in patients using antihypertensive medication.<bold>Methods: </bold>The CATI study is a randomised controlled trial that will be performed in 13 community pharmacies. Patients aged 45-75 years using antihypertensive medication and considered non-adherent according to pharmacy dispensing data, as well according to a self-report questionnaire, are eligible to participate. Patients in the intervention condition will receive a patient-tailored, pharmacist-led intervention programme. This programme consists of a structured interview at the pharmacy to identify patients' barriers to adherence and to counsel patients in order to overcome these barriers. The primary outcome is self-reported medication adherence measured with the MARS-5 questionnaire. Secondary outcome measures are blood pressure, illness perceptions, quality of life and societal costs. A cost-effectiveness analysis and process evaluation will also be performed.<bold>Discussion: </bold>This study will provide insight into the (cost-)effectiveness of a patient-tailored, pharmacist-led intervention programme in non-adherent patients using antihypertensive medication. This intervention programme allows community pharmacists to support their patients in overcoming barriers to adherence and improving medication adherence in a structured and patient-tailored manner. An effective intervention will not only enhance medication adherence, but may also improve health outcomes and decrease health care utilisation and costs.<bold>Trial Registration: </bold>Netherlands Trial Register (identifier: NTR5017), registered on 2 February 2015. [ABSTRACT FROM AUTHOR]
- Subjects :
- *COST effectiveness
*HEALTH care intervention (Social services)
*PATIENT compliance
*ANTIHYPERTENSIVE agents
*DRUGSTORES
*RANDOMIZED controlled trials
*CARDIOVASCULAR system
*COUNSELING
*BLOOD pressure
*COMPARATIVE studies
*DRUGS
*EXPERIMENTAL design
*INTERVIEWING
*HYPERTENSION
*RESEARCH methodology
*MEDICAL care costs
*MEDICAL cooperation
*PHARMACISTS
*RESEARCH
*TIME
*OCCUPATIONAL roles
*EVALUATION research
*TREATMENT effectiveness
*ECONOMICS
*DIAGNOSIS
Subjects
Details
- Language :
- English
- ISSN :
- 17456215
- Volume :
- 18
- Database :
- Academic Search Index
- Journal :
- Trials
- Publication Type :
- Academic Journal
- Accession number :
- 120915262
- Full Text :
- https://doi.org/10.1186/s13063-016-1696-3